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VANGL2 regulates luminal 
epithelial organization and cell 
turnover in the mammary gland
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Patrick O. Humbert  2,3,8,9,10 & Lindsay Hinck1
The VANGL family of planar cell polarity proteins is implicated in breast cancer however its function 
in mammary gland biology is unknown. Here, we utilized a panel of Vang1 and Vangl2 mouse alleles 
to examine the requirement of VANGL family members in the murine mammary gland. We show that 
Vang1CKOΔ/Δ glands display normal branching while Vangl2flox/flox and Vangl2Lp/Lp tissue exhibit several 
phenotypes. In MMTV-Cre;Vangl2flox/flox glands, cell turnover is reduced and lumens are narrowed. 
A Vangl2 missense mutation in the Vangl2Lp/Lp tissue leads to mammary anlage sprouting defects 
and deficient outgrowth with transplantation of anlage or secondary tissue fragments. In successful 
Vangl2Lp/Lp outgrowths, three morphological phenotypes are observed: distended ducts, supernumerary 
end buds, and ectopic acini. Layer specific defects are observed with loss of Vangl2 selectively in either 
basal or luminal layers of mammary cysts. Loss in the basal compartment inhibits cyst formation, but 
has the opposite effect in the luminal compartment. Candidate gene analysis on MMTV-Cre;Vangl2flox/flox 
and Vangl2Lp/Lp tissue reveals a significant reduction in Bmi1 expression, with overexpression of Bmi1 
rescuing defects in Vangl2 knockdown cysts. Our results demonstrate that VANGL2 is necessary for 
normal mammary gland development and indicate differential functional requirements in basal versus 
luminal mammary compartments.
Recent studies have implicated the planar cell polarity (PCP) genes VANGL1 and VANGL2 in breast cancer1. 
A high level of VANGL1 expression is associated with poor prognosis and relapse in breast cancer patients2. 
Similarly, upregulation of VANGL2 was identified in the more aggressive basal type tumors and is also associated 
with poor prognosis3. While alterations of VANGL1 and VANGL2 in breast cancer have been investigated, their 
function in normal breast development is still unknown. Here we provide the first analysis of VANGL function 
in mammary gland development in vivo.
The mammary gland is a branched organ with epithelial ducts that grow outward from the nipple into a sur-
rounding fat pad. These ducts are bi-layered structures, composed of an outer basal layer of contractile myoepi-
thelial cells and an inner luminal layer of secretory cells. Mammary identity is established early in the developing 
embryo. By E11.5, FGF and WNT signals drive cell fate specification in order to produce the first mammary 
epithelium4. This group of cells further expands around E15.5 to form a mammary bud. At birth, the mammary 
gland exists as a rudimentary tree with few branches and a hollow lumen. The mammary gland then remains 
quiescent until puberty when it undergoes massive growth by branching. During branching morphogenesis, end 
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buds (EBs) establish the mammary tree through two types of branching. Initially, a small number of terminal 
EBs (TEBs) sprout into the fat pad and, through coordinated migration and bifurcation events, produce primary 
branches that extend from the nipple to the outer edges of the fat pad. Next, lateral end buds form on the sides of 
primary branches and sprout secondary and tertiary branches. The formation and expansion of EBs in the mam-
mary gland relies on the precise deployment of extracellular signals. One of the major drivers of mammary gland 
morphogenesis is WNT signaling5.
WNT signaling can be divided into canonical and non-canonical pathways. Canonical WNT signaling has 
been implicated in multiple aspects of mammary gland development5, however, details regarding non-canonical 
WNT signaling in the mammary gland remain elusive. The non-canonical WNT/Planar cell polarity (PCP) sign-
aling axis propagates directional information across sheets of epithelium. At the core of PCP signaling is the Van 
Gogh Like (VANGL) family of transmembrane proteins: VANGL1 and VANGL26. One of the VANGL family 
proteins, VANGL2, is required for proper branching and tubulogenesis of the kidney and lung, but the exact 
mechanism of this action is unknown7–11.
To examine the requirement of VANGL family members in the murine mammary gland, we utilized a panel 
of Vang1 and Vangl2 mouse alleles. Here, we report that Vangl2 missense and loss-of-function mutations stunt 
mammary gland development whereas a Vangl1 hypomorphic mutation does not affect mammary outgrowth 
or branching morphogenesis. In addition, using different Vangl2 alleles, we demonstrate that loss of cell sur-
face VANGL2 results in different phenotypes compared to Vangl2 deletion. Using in vitro primary cultures, we 
show that VANGL2 has distinct functions in the basal and luminal cell compartments. Finally, we show that loss 
of Vangl2 lowers expression of the polycomb group repressor Bmi1 and hinders cyst formation, while overex-
pression of the gene rescues cyst formation in vitro. Our studies provide insight into mechanisms that control 
growth and development in the mammary gland and show a novel mechanism for PCP signaling in influencing 
transcriptional repressors. Our studies also further broaden the scope of non-canonical WNT signaling in the 
mammary gland and draw useful comparisons between different Vangl loss-of-function models.
Results
Vangl2 is expressed in multiple cell populations in the mammary gland. To establish the role of 
PCP genes Vangl1 and Vangl2 in the mammary gland, we initially examined their mRNA levels using RT-qPCR. 
Cells isolated from mammary glands harvested from adult wildtype (WT) mice were FACS purified into three 
subpopulations: basal (Lin-CD24+CD29hi), mature luminal (Lin-CD24loCD29+CD61−), and luminal progenitor 
(Lin-CD24loCD29+CD61+). RNA isolated from each cell type was subjected to RT-qPCR using primers specific 
to Vangl1 and Vangl2. Results from these experiments show Vangl1 and Vangl2 expressed in all mammary cell 
populations (Fig. 1A). Re-analysis of a previously published GEO dataset (GSE19446)12 that profiled FACS sorted 
normal mouse mammary cell subpopulations independently supported this observation (Supp. Fig. 1).
Figure 1. Vangl1 and Vangl2 expression in the mammary gland. (A) RT-qPCR analysis of Vangl1 and Vangl2 
mRNA levels in FACS-purified basal (Bsl), mature luminal (ML), and luminal progenitor (LP) cells (n = 3).  
(B) Quantification of basal cells positive for VANGL1 (V1) or VANGL2 (V2) by immunofluorescence in mature 
virgin glands. Immunostained WT 8 weeks old mammary tissue shows levels of VANGL1 (green) with Smooth 
Muscle Actin (SMA)(red), and (D) VANGL2 (green) with Cytokeratin 14 (K14)(red). (E,F) Representative 
immunoblots (E) and quantification (F) of VANGL2, Cytokeratin 18 (K18) and GAPDH (control) in proximal 
(P), Central (C) and Distal (D) regions of 8 weeks old mammary gland. HEK293 lysate was used as the control 
(Ctrl) sample (n = 3). (G) Immunostained 5.5 weeks old WT gland shows VANGL2 (green) in a bifurcating TEB 
(nuclei, blue). Data are represented as mean +/− SEM. Scale bars represent 20 μm. Two way ANOVA *p < 0.05 
and ***p < 0.001.
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Previous studies have linked the function of VANGL1 and VANGL2 to their subcellular localization, and 
their role in PCP is characterized by their membrane localization at the apical epithelial cell junctions and within 
recycling endosomes13. In order to better understand these proteins in the mammary gland, we investigated the 
subcellular localization of the VANGL proteins by immunohistochemical analysis of sectioned mammary glands 
from mature virgin mice stained with antibodies generated against VANGL1, VANGL2, and basal lineage mark-
ers K14 and SMA. Consistent with the mRNA expression, VANGL1 and VANGL2 were expressed in all luminal 
cells and approximately 70% of basal cells (Fig. 1B). Within each cell, VANGL1 and VANGL2 were found both at 
the membrane, consistent with their role in cell/cell interactions, and in a punctate pattern within the cytoplasm, 
consistent with their active regulation by endocytosis (Fig. 1C,D)13.
Previous studies have shown the importance of graded VANGL2 expression during tissue morphogenesis14. 
To further investigate the role of VANGL2 in the adult mammary gland, we quantified protein levels across the 
gland. To this end, we harvested mammary glands from WT mature virgin mice, cut the tissue into the proximal 
(near nipple, P), central (C) and distal (TEB-containing, D) regions and used protein isolated from each region 
for immunoblotting with antibodies against VANGL2, K18 (luminal cells) and GAPDH (loading control). We 
found VANGL2 present in a gradient from the nipple to the TEBs, with a 5-fold VANGL2 increase in the cen-
tral and a 15-fold increase in the distal, compared to the proximal, regions (Fig. 1E,F, Supp. Fig. 4). To examine 
VANGL2 subcellular localization in distal TEBs, where it is more concentrated, we micro-dissected them and 
immunostained with anti-VANGL2 antibodies. We observed VANGL2 staining in a punctate pattern in the cyto-
plasm and at the membrane in the unpolarized luminal cells (body cells) that constitute the body of the end bud 
(Fig. 1G), suggesting a role for VANGL2 in TEBs during ductal morphogenesis. Taken together, these results 
show both VANGL1 and VANGL2 are expressed in mammary epithelial cells and suggest a role for the proteins 
in the development of the mammary gland.
Vangl1 is dispensable for normal mammary morphogenesis. VANGL1 and VANGL2 are trans-
membrane proteins that rely on cell surface expression to carry out PCP signaling15–17. In order to investigate the 
role of VANGL1 and VANGL2 in the mammary gland, we examined the loss-of-function phenotypes of these 
proteins using mice carrying mutations that disrupt trafficking of the proteins to the cell surface. The previously 
described Vangl1CKO mice15 were generated by using the HRPT-Cre allele to delete all of the transmembrane 
domains of Vangl1 in the germline. Consequently, these homozygous deleted mice (Vang1CKOΔ/Δ) produce a 
VANGL1 protein that is improperly trafficked to the membrane, disrupting the function of VANGL1 in PCP. To 
investigate the overall structure of Vangl1CKOΔ/Δ mammary glands, we carmine stained whole mounted glands 
from mature virgin mice and observed a fully expanded mammary epithelial tree, characterized by ducts reach-
ing the outer edges of the fat pad in a growth pattern similar to WT (Fig. 2A). We performed branching analysis 
to assay TEB bifurcation (primary branching) and secondary/tertiary branching and discovered no significant 
difference between WT and Vangl1CKOΔ/Δ tissue (Fig. 2B–D). We further investigated the role of VANGL1 in 
mammary morphogenesis by examining cell morphology in Vangl1CKOΔ/Δ glands. To confirm mislocalization of 
VANGL1, we immunostained with anti-VANGL1 and observed an increase in puncta localized in the cytoplasm 
of Vangl1CKOΔ/Δ tissue (Fig. 2E). This observation was consistent with a previously described trafficking defect15. 
Additionally, we immunostained with anti-CDH1 and observed a normal epithelial staining pattern in both WT 
and Vangl1CKOΔ/Δ tissue, with E-cadherin localized to cell junctions (Fig. 2E). Together, these data suggest that 
VANGL1 signaling at the plasma membrane is dispensable in mammary development.
Loss of Vangl2 impairs cell turnover and generates compacted ducts with narrow lumens. To 
investigate the consequences of Vangl2 deletion in the mammary gland in the context of normal Vangl1 
expression, we utilized a previously developed floxed allele of Vangl2 consisting of loxP sites flanking exon 418. 
Expression of Cre in these mice introduces a premature stop codon and subsequent loss of all four transmem-
brane domains and the C-terminal PDZ-binding motif. To specifically delete Vangl2 in the mammary epithelium, 
we crossed these mice with MMTV-Cre transgenic mice that delete floxed genes in both luminal and basal mam-
mary epithelial cells19. We then confirmed dose dependent loss of Vangl2, but not Vangl1, in the mammary glands 
of MMTV-Cre;Vangl2flox/+ and MMTV-Cre;Vangl2flox/flox mice by RT-qPCR (Fig. 3A). To assess the developmental 
impact of VANGL2 loss on branching, we examined whole mount preparations of inguinal mammary glands 
from mature virgin mice. We observed no change in branch number or ductal extension (Fig. 3B). Next we per-
formed histological analysis on H&E stained mammary gland sections from MMTV-Cre, MMTV-Cre;Vangl2+/flox, 
and MMTV-Cre;Vangl2flox/flox mice. We found that MMTV-Cre;Vangl2flox/flox glands contained significantly 
narrower ducts, as measure by luminal width, than MMTV-Cre;Vangl2flox/+ or MMTV-Cre controls (Fig. 3C) 
(p < 0.03). These results suggest a pronounced defect in duct widening characterized by a near absence of luminal 
space in the absence of VANGL2.
To determine if changes in cellular size or composition are associated with narrowed ducts, we performed 
immunostaining using luminal (K8) and basal (K5, SMA) differentiation markers. These analyses found that 
although Vangl2-deficient ducts were narrow, they retained a normal bilayered epithelium consisting of single 
layers of luminal and basal cells of a similar size and shape to normal control cells (Fig. 3D). The maturation and 
proper formation of the mammary epithelium is characterized by the specification of distinct apical and baso-
lateral membrane identities1. Because VANGL2 is a key cell polarity gene, we next examined the polarization of 
apical membrane domains and formation of basolateral adherence junctions in these narrow ducts. We observed 
intact expression of E-cadherin (anti-CDH1) along cell-cell boundaries and apical expression of phosphor-ezrin/
radixin/moesin (anti-pERM) along all cell membranes exposed to luminal space (Fig. 3E). Altogether these stud-
ies suggest that Vangl2-deficient cells are capable of differentiating and responding to key polarization cues during 
ductal morphogenesis despite abnormal ductal morphogenesis.
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We next investigated whether the narrowed ducts were a result of changes in proliferation and/or apopto-
sis by performing Ki67 and Cleaved Caspase 3 immunohistochemistry on mature virgin MMTV-Cre;Vanglflox/+ 
and MMTV-Cre;Vanglflox/flox glands. We detected significantly lower rates of both proliferation and apoptosis in 
Vangl2-deficient mammary epithelium compared to control (Fig. 3F,G). These findings support previous work 
suggesting that cellular turnover mediated by mitogenic signaling and pro-apoptotic factors, such as BCL2L11 
(BIM), is an essential process for proper lumen formation and maintenance in the mammary gland20. During 
ductal morphogenesis, we also detected lower proliferation within the ducts, but not TEBs, of 6 weeks old mice 
(Supp. Fig. 2A). Taken together, these results suggest that VANGL2 plays a specific role in mammary duct homeo-
stasis, not in cell differentiation or duct elongation, but specifically in duct maturation and lumen expansion, and 
the defects observed in the absence of VANGL2 may result from inappropriate cell turnover and proliferation.
Deregulation of VANGL2 function stunts mammary outgrowth. Next, we investigated disrup-
tion of both Vangl1 and Vangl2 by examining the well-characterized Looptail (Vangl2Lp/Lp) mice, which har-
bor a missense mutation in the Vangl2 gene that interrupts both VANGL1 and VANGL2 trafficking to the cell 
surface21,22. This mutation results in severe PCP defects in multiple organs, leading to embryonic lethality23. To 
study the mammary gland, which develops postnatally, we followed standard protocols to generate Vangl2Lp/Lp  
mammary outgrowths via anlage rescue24. This entailed harvesting E16.5 mammary anlage from Vangl2Lp/Lp and 
WT embryos and contralaterally transplanting them into adult hosts that had been pre-cleared of endogenous 
mammary epithelium. To determine if VANGL1 was altered in the Vangl2Lp/Lp mammary epithelium, we immu-
nostained sectioned WT and Vangl2Lp/Lp tissue with anti-VANGL1 and found reduced levels of VANGL1, espe-
cially along the cell borders in the luminal compartment, in the mutant compared to WT (Supp. Fig. 2B). Whole 
mount analysis of tissue harvested 12-weeks post-transplantation showed that tissue transplanted from Vangl2Lp/
Lp embryos generated fewer outgrowths compared to WT (Fig. 4A). To quantify, we defined no outgrowth as 
fat pads having less than 10% of their area filled with epithelium. Our analysis found that 32% (7/22) of fat 
pads transplanted with Vangl2Lp/Lp anlage had outgrowths compared to 60% (18/30) of WT (Fig. 4B). To address 
whether this phenotype was due to transplantation of embryonic tissue, we performed a secondary transplant 
by harvesting a tissue fragment from each of the 7 mature Vangl2Lp/Lp and 5 mature WT outgrowths and trans-
planting it into a new host fat pad. We again observed deficient transplantability of Vangl2Lp/Lp tissue. In this 
experiment, 44% (20/45) of fat pads containing Vangl2Lp/Lp transplants generated an outgrowth compared to 93% 
Figure 2. Loss of VANGL1 does not affect mammary growth or branching. (A) Representative images of ductal 
outgrowth in carmine stained WT and Vangl1CKOΔ/Δ mammary glands at 8 weeks. Quantification of primary 
(B), secondary and tertiary branching (C) and TEBs (D) (n = 3 mice per genotype). (E) Immunostaining tissue 
from WT (top) and Vangl1CKOΔ/Δ (bottom) mammary glands from 8 weeks old mice shows localization of 
VANGL1 (green) on the cell borders (WT) or in a punctate pattern in the cytosol (Vangl1CKOΔ/Δ) of mammary 
epithelial cells (left), E-cadherin (CDH1) (red) on cell borders of both WT and Vangl1CKOΔ/Δ tissue (middle), 
and merged VANGL1 and E-cadherin (right). Data are represented as mean +/− SEM. Scale bars represent 
1.5 mm (A) and 20 μm (E). Student’s t-test ns = not significant.
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Figure 3. Deletion of Vangl2, but not Vangl1, in the mammary gland results in narrow ducts and low cell turnover. 
(A) RT-qPCR analysis of Vangl1 and Vangl2 mRNA levels in the mammary glands of MMTV-Cre, MMTV-
Cre;Vangl2flox/+ and MMTV-Cre;Vangl2flox/flox at 10 weeks of age. (B) Representative images of 10 week old, carmine 
stained mammary glands and quantification of total branch number from MMTV-Cre, MMTV-Cre;Vangl2flox/+ 
and MMTV-Cre;Vangl2flox/flox mice (n = 3 mice per genotype). (C) Histological analysis by H&E staining show 
normal duct formation in 10 week old MMTV-Cre and MMTV-Cre;Vangl2flox/+ glands, whereas ducts from 
MMTV-Cre;Vangl2flox/flox glands are narrow and have significantly diminished lumens (n = 3 mice/genotype). (D) 
Immunostaining in mammary ducts show normal distribution of luminal (Cytokeratin 8 (K8), green), and basal (K5), 
red; SMA magenta) cell populations. (E) Immunofluorescence of adhesion junctional protein E-Cadherin (CDH1, 
green) and apical membrane marker pERM (red). (F,G) Immunostaining in 10 week old MMTV-Cre;Vangl2+/+ and 
MMTV-Cre;Vangl2flox/flox glands and quantitation of (F) Ki67 and (G) Cleaved Caspase 3 (n = 3–5 mice per genotype). 
Lu indicates lumen. * indicates non-magnified duct. Data are represented as mean +/− SEM. Scale bar represents 
100 μm (C,F,G) 50 μm (D) and 10 μm (E). Student’s t-test *p < 0.05 and ****p < 0.0001.
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(42/45) of those transplanted with WT (Fig. 4B). These data suggest that the effect of VANGL2 signaling on out-
growth potential persists from embryonic to adult tissue and could be influencing the stem cell population that 
drives embryonic and postnatal growth.
Given that stem cells, residing in the basal layer, drive outgrowth in the mammary gland and that our results 
show expression of VANGL2 in basal cells and stunted growth in Vangl2Lp/Lp outgrowths, we investigated the role 
of VANGL2 in stem cell self-renewal activity. Adult stem cells in the mammary gland are responsible for fueling 
postnatal growth of the gland. Previous studies have shown that mammary stem cell self-renewal can be assayed 
by serial transplantation whereby stem cells are challenged with growing an entire gland after each passage of a 
tissue fragment25,26. To this end, we serially transplanted contralateral WT and Vangl2Lp/Lp outgrowths and found 
they lost regenerative capacity at generation 4 and 5, respectively, suggesting that VANGL2 does not signifi-
cantly alter tissue passageability. However, consistent with our previous data, WT tissue transplants generated 1.5 
times more positive outgrowths in the first two passages compared to Vangl2Lp/Lp (Fig. 4C). Taken together, these 
data suggest that loss of cell surface VANGL proteins significantly reduces the outgrowth potential, but not the 
self-renewal capacity, of stem cells.
Vangl2Lp/Lp embryos contain either stunted anlage or anlage containing supernumerary 
embryonic sprouts. The large percentage of Vangl2Lp/Lp anlage rescue experiments that did not produce 
Figure 4. Limited mammary transplant reconstitution capacity and embryonic anlagen defects in Vangl2Lp/Lp  
mice. Representative images (A) and quantification (B) of ductal outgrowth in carmine stained WT and or 
Vangl2Lp/Lp tissue 12 weeks post-transplantation. For G0 (n = 9 WT embryos and 6 Vangl2Lp/Lp embryos) and G1 
(n = 45 mice with contralateral WT and Vangl2Lp/Lp outgrowths). (C) Fragments from WT and Vangl2Lp/Lp  
outgrowths were serially transplanted at 8 week intervals (generations) (n = 5 mice per generation). (D) 
Representative images of WT (left) and Vangl2Lp/Lp (right) E16.5 mammary anlage immunostained with 
K14 display no branching and hyperbranching phenotypes in the mutant. (E) Quantification of sprouting in 
WT and Vangl2Lp/Lp anlage. (F) Representative images of WT (left) and Vangl2Lp/Lp (right) E16.5 mammary 
anlage immunostained with K14 and K8 show bi-layered structures. Numbers denote branches. n = 8 WT 
and 8 Vangl2Lp/Lp embryos. Scale bars represent 40 μm. Data are represented as mean ± SEM. Students t-test 
**p < 0.01.
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mammary outgrowths suggests that development of the mammary anlage may be compromised in Vangl2Lp/Lp 
animals. To investigate, we examined Vangl2Lp/Lp mammary rudiments in intact embryos. By E16.5 the mammary 
gland is specified and has undergone bifurcation to generate 3 sprouts4. Using fluorescent whole mount immu-
nostaining with anti-K14, we visualized the overall structure of E16.5 WT and Vangl2Lp/Lp mammary anlage. 
Three-dimensional reconstruction revealed 100% of WT anlage produced three sprouts (Fig. 4D,E), whereas 50% 
of Vangl2Lp/Lp anlage had no sprouts, generating instead a large bud-like structure (Fig. 4D,E). This observation 
suggests that the lack of VANGL on the cell surface compromises the ability of the embryonic mammary bud to 
break symmetry, bifurcate and generate branches. Furthermore, the lack of prenatal branching in 50% of exam-
ined embryo anlage likely relates to the remarkably similar incomplete penetrance we observed in the outgrowth 
efficiency of transplanted Vangl2Lp/Lp anlage (Fig. 4A,B).
Next, we examined the 50% of Vangl2Lp/Lp anlage that developed past the tissue bud stage and formed branched 
structures. We found that only 40% of these Vangl2Lp/Lp anlage formed a typical rudimentary tree with 3 distin-
guishable sprouts, similar to the 3-pronged structure of WT anlage (Fig. 4E). The remaining 60% of Vangl2Lp/Lp 
anlage contained 4 or more sprouts (Fig. 4D,E). Whole mount immunohistochemistry with basal (anti-K14) and 
luminal (anti-K8) cell markers revealed that both WT and Vangl2Lp/Lp anlage are composed of K8 and K14 posi-
tive cells, suggesting bilayer formation was unaffected by loss of surface VANGL function (Fig. 4F). Together, the 
data demonstrate a role for VANGL signaling in generating proper tissue structure during the critical early stages 
of mammary gland development.
Vangl2Lp/Lp outgrowths display supernumerary end buds and ectopic acini. Given that TEBs are 
the site of growth and proliferation in the mammary gland and VANGL2 is highly expressed in this region, 
we performed additional transplantation experiments to evaluate the postnatal consequences of VANGL 
loss-of-function in successful mammary outgrowths. We observed three distinct phenotypes in Vangl2Lp/Lp out-
growths (n = 20 WT/LP pairs) that were non-mutually exclusive. One phenotype was an abundance of end buds. 
We found that 45% (9/20) of Vangl2Lp/Lp outgrowths contained 6-fold more TEBs that were significantly larger 
compared to WT (Fig. 5A–C,I, Supp. Fig. 2C). Together, these findings suggest that VANGL2 is expressed in a 
gradient across the gland and loss of this graded expression enhances TEB formation.
A second phenotype (8/20) was the formation of premature acini (Fig. 5D,E,I). Our transplantation assays 
were performed such that WT fragments were contralaterally transplanted into the same mouse as Vangl2Lp/Lp 
tissue. Therefore, both tissues were exposed to the same hormonal environment so this defect does not represent 
cyclic side branching. Nevertheless, we found that Vangl2Lp/Lp outgrowths contained twice as many acini per duct, 
compared to WT (Fig. 5D,E,I, Supp. Fig. 2D). To evaluate the morphology of these structures, we sectioned WT 
and Vangl2Lp/Lp tissue and immunostained with anti-CDH1, revealing a single layer of luminal cells surrounding 
a hollow lumen (Supp. Fig. 2E). In contrast, multiple layers of disorganized luminal cells frequently occluded 
Vangl2Lp/Lp acini (Supp. Fig. 2E). Thus, WT acini morphologically mimicked normal tertiary branching, whereas 
Vangl2Lp/Lp acini showed exuberant, disorganized, tertiary acini, despite being exposed to the same hormonal 
environment.
A third phenotype (6/20) was the presence of dilated ducts (Fig. 5G–I, Supp. Fig. 2F). We quantified the size 
of these ducts along their length by optically dividing each duct into horizontal sections using a grid and found 
that the average area of Vangl2Lp/Lp ducts was 3 times greater than WT (Fig. 5G). In addition to their increased 
size, Vangl2Lp/Lp ducts are also marked by pronounced constrictions along their lengths, giving the ducts a pinched 
appearance (Fig. 5H). In contrast, WT ducts are uniform in size; even if their area is expanding or contract-
ing, the change is gradual (Fig. 5H). This difference was reflected in the quantification where we observed WT 
measurements clustering around 20 a.u., whereas Vangl2Lp/Lp measurements were more variable, echoing the 
abrupt changes in ductal size occurring over the length of Vangl2Lp/Lp ducts (Fig. 5G,H). Actin polymerization 
plays an important role in regulating lumen formation, and disorganized actin patterns have been observed in 
tubular and ductal organs of Vangl2Lp/Lp animals7–9. To evaluate the filamentous actin cytoskeleton, we sectioned 
and phalloidin stained WT and Vangl2Lp/Lp tissue, observing irregular f-actin organization and reduced staining, 
particularly in the luminal compartment of Vangl2Lp/Lp ducts (Supp. Fig. 2G). In order to investigate whether this 
phenotype was due to a loss in PCP signaling, we examined the morphology of mammary glands from another 
PCP mutant mouse, Prickle2 (Pk2). PK2 is a cytoplasmic mediator of PCP signaling downstream of VANGL227. 
Immunostaining of sectioned glands obtained from mature virgin mice with anti-PK2 antibodies revealed cyto-
plasmic and membrane staining in a pattern similar to VANGL2 expression (Supp. Fig. 2H). Pk2 mutant mice 
have an embryonic lethal phenotype, resulting in termination around E3.5 before the mammary rudiment is 
formed28. This prevented anlage rescue; therefore instead, we harvested mammary glands from adult virgin WT 
and Pk2+/− mice and performed whole mount analysis. Similar to WT, we found that Pk2+/− glands filled 100% 
of the fat pad (Supp. Fig. 2I), but Pk2+/− ducts were dilated except for constrictions, a phenotype also observed 
in Vangl2Lp/Lp outgrowths (Fig. 5G,H). Taken together these results suggest that loss of surface VANGL signaling 
regulates mammary ductal diameter.
Depletion of VANGL2 in basal versus luminal cell populations alters cyst formation. Expression 
of VANGL2 in both the luminal and basal subpopulations, and the range of phenotypes displayed in the Vangl2Lp/Lp  
outgrowths, suggest that VANGL2 is governing different aspects of mammary gland development, perhaps by 
differentially influencing cell interactions and signaling in the distinct basal and luminal compartments of the 
mammary gland. To test this hypothesis, we used differential trypsinization to separate the two subpopulations29 
and lentiviral-mediated knock down to reduce expression of Vangl2 in either the basal, luminal or both cell 
types (Supp. Fig. 3A,B,4). By mixing knock down (KD) and WT subpopulations of cells and culturing them in 
Matrigel in the absence of growth factors, we generated mammary cysts that were mosaic in the expression of 
VANGL2, such that either the basal or luminal compartment was VANGL2-deficient (Fig. 6A). As a control, we 
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also generated KD and WT cysts in which both or neither compartments were VANGL2-deficient (Fig. 6A). WT 
cells formed round cysts with approximately 3 protrusions, whereas KD cysts were half the size with no protru-
sions (Fig. 6B,C). KD of Vangl2 in the luminal layer produced cysts similar in overall appearance to WT but 3-fold 
larger (Fig. 6A,B). Consistent with this increase in size, the KD cysts had 2-fold more cell protrusions (Fig. 6A,C). 
We immunostained these cysts with lineage markers K14 and K8 (Fig. 6D). Optical sections through these cysts 
show that, while WT cysts have clear lumens, Vangl2 luminal KD cysts contained a filled lumen. These data show 
that loss of VANGL2 in the luminal population leads to disorganization, which echoes the TEB and acinar phe-
notypes in the Vangl2Lp/Lp full outgrowths and the narrowed lumen phenotype in the MMTV-Cre;Vangl2flox/flox  
glands. In contrast, KD of Vangl2 in the basal layer, which contains a subpopulation of mammary stem cells, 
yielded cysts that resembled the full Vangl2 KD cysts: half the size of WT with half the number of protrusions 
Figure 5. Vangl2Lp/Lp outgrowths display distinct morphological defects. (A) Magnified view of supernumerary 
end buds in Vangl2Lp/Lp tissue from carmine stained, contralaterally transplanted WT and Vangl2Lp/Lp 
outgrowths 12 weeks post-transplantation; WT outgrowth contains no supernumerary end buds. Quantification 
of the area (B) and number (C) of end buds in WT and Vangl2Lp/Lp outgrowths. (D) Magnified view of acini in 
Vangl2Lp/Lp tissue from carmine stained, contralaterally transplanted Vangl2Lp/Lp tissue; WT outgrowth contains 
no acini. Arrow shows tertiary branching. Arrowhead denotes acinar structure. (E) Quantification of the 
number of acini in WT and Vangl2Lp/Lp outgrowths. (F) Magnified view of dilated ducts in tissue from carmine 
stained, contralaterally transplanted WT and Vangl2Lp/Lp outgrowths, harvested at 12 weeks; WT outgrowth 
shows smooth ductal borders with no constrictions. (G) Quantification of ductal size in WT, Vangl2Lp/Lp and 
Pk2 +/− tissue (n = 10 ducts from 3 mice per genotype). (H) Representative images of carmine stained WT 
outgrowth, Vangl2Lp/Lp outgrowth and Pk2 +/−  ducts and displaying pinched ductal phenotype. Arrows denote 
constrictions. (I) Cartoon representation of the distinct phenotypes observed in Vangl2Lp/Lp outgrowths: DD, 
dilated ducts; SE, supernumerary end buds; A, acini. Scale bars represent 1.5 mm. Data are represented as 
mean ± SEM. Students t-test *p < 0.05, ***p < 0.001, and ****p < 0.0001.
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(Fig. 6A–C). The small size and number of these basal cysts prevented us from successfully immunostaining 
them. These studies suggest that VANGL2 has different functions in the luminal and basal compartments, 
restricting cyst formation in the luminal compartment while promoting cyst formation in the basal compartment.
Figure 6. Knockdown of Vangl2 in the basal versus luminal layers of cysts alter morphology. (A) Schematic (top) and 
representative images (bottom) of mosaic cysts after 4 days in culture. Quantification of cyst size (B) and number of 
protrusions (C) in the mosaic cysts. (D) Immunostaining of K14 (red) and K8 (green) showing the surface (top) or 
inside (bottom) of WT or mosaic cysts with Vangl2 knocked down in only luminal cells. Representative images (E) 
and quantification (F) of rescue of Vangl2 KD cyst size with overexpression of Bmi1. n = 3 biological replicates. Scale 
bars represent 20 μm. Data are represented as mean ± SEM. Students t-test *p < 0.05.
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To further understand VANGL2 signaling in the mammary gland, we performed RT-qPCR on cDNA generated 
from Vangl2Lp/Lp and WT outgrowths and mammary tissue derived from MMTV-Cre;Vangl2flox/flox and MMTV-Cre 
only mice to evaluate the expression of genes encoding proteins that mediate the downstream signaling func-
tions of VANGL2. To probe canonical WNT signaling, we measured expression of Axin2. In addition, as previous 
studies have shown that VANGL2 is a regulator of SHH, we evaluated SHH signaling by measuring the expres-
sion of downstream effectors Bmi1 and Ptch130. Although we found no change in Axin2 or Ptch1 expression in 
Vangl2Lp/Lp outgrowths compared to WT (Supp. Fig. 3C), we did observe a decrease in both Axin2 and Ptch1 in 
MMTV-Cre;Vangl2flox/flox compared to MMTV-Cre only mice (Supp. Fig. 3D). Importantly we observed a significant 
and consistent down regulation of Bmi1 in both Vangl2Lp/Lp outgrowths and MMTV-Cre;Vangl2flox/flox mammary 
tissue compared to respective WT controls (Supp. Fig. 3C,D). BMI1 is part of the polycomb repressive complex 1 
(PRC1) that maintains genes in a transcriptional repressive, quiescent state. Loss of its expression in Vangl2Lp/Lp tissue 
could explain our difficulty rescuing Vangl2Lp/Lp anlage, propagating the tissue in vivo and generating cysts with KD 
of Vangl2 in the basal, stem cell containing compartment of the mammary gland. To investigate, we overexpressed 
Bmi1 in Vangl2 KD cysts and found that reconstitution of Bmi1 expression rescued the formation of cysts that were 
the same size as those generated with scrambled shRNA (Fig. 6E,F). These results show an inverse relationship 
between VANGL2 and Bmi1 expression and suggest this may regulate the viability and outgrowth of mammary cells.
Discussion
Although non-canonical WNT signaling has been shown to have an important role in normal mammary gland 
development, the mechanisms underlying the process remain elusive31. WNTs have both diverse and vast influ-
ences on mammary morphogenesis that can be explained by their ability to engage various receptors. In this 
study, we address non-canonical WNT/PCP signaling by directly examining the consequences of aberrant 
VANGL receptor function. We found that both VANGL1 and VANGL2 are expressed in the mammary gland 
and can be detected by immunostaining in the same cell populations; however, their loss-of-function phenotypes 
are different. We discovered that VANGL2 plays a more important role in both embryonic and postnatal gland 
development compared to VANGL1. We also observed distinct VANGL2 phenotypes depending on the genetic 
approach we used. Conditional loss of VANGL2 during puberty in the MMTV-Cre; Vangl2flox/flox mice led to 
defects in post-natal mammary duct morphogenesis whereas aberrant VANGL2 signaling during embryonic 
development in Vangl2Lp/Lp transplants resulted in a range of embryonic and differentiation defects consistent 
with impaired stem cell function.
One phenotype shared between both of our models is mis-regulation of ductal size. The non-canonical Wnt/
PCP pathway regulates ductal diameter in a variety of epithelia by controlling two morphogenetic processes: con-
vergent extension (CE) and oriented cell divisions (OCD). In this way, length-wise extension of tubules through 
OCDs is balanced with the reorganization of cells along the width via CE, and, together, these mechanisms reg-
ulate ductal diameter. The MMTV-Cre;Vangl2flox/flox mammary glands display narrow ducts, whereas Vangl2Lp/Lp 
outgrowths contain ducts that are either uniformly wide or wide but marked with constrictions. These pheno-
types suggest a role for VANGL2 in regulating mammary ductal diameter and are consistent with luminal width 
defects previously observed in Vangl2 mutant mice. For example, embryonic and adult airway lumen in the lungs 
of Vangl2Lp/Lp and Vangl2Lp/+ mice, respectively, are absent or narrow8,32, a phenotype that is reminiscent of the 
narrow lumens observed in MMTV-Cre;Vangl2flox/flox mammary glands (Fig. 3C). In contrast, dilated lumens 
are observed in both Podocin-Cre;Vangl2flox/flox and Vangl2Lp/Lp embryonic kidneys7,9,10. Recent studies show that 
OCDs are significantly off axis in Vangl2Lp/Lp embryonic kidneys compared to WT, leading to wider lumens11. 
Thirty percent of Vangl2Lp/Lp mammary glands display dilated ducts, with some containing points of marked nar-
rowing (Fig. 5F–H). Thus, it is likely that VANGL2 controls OCDs during mammary morphogenesis, but confir-
mation will require analysis of cell divisions and movements that occur over a longer time frame in the postnatal 
mammary gland. In addition, a number of other mechanisms have been implicated in mammalian lumen size 
control including RhoGTPase regulated actomyosin contractility, a known downstream effector of PCP signaling 
activity, and fluid-driven lumen expansion33. We did observe reduced proliferation in MMTV-Cre;Vangl2flox/flox 
mammary glands (Fig. 3F), which may contribute to abnormal duct formation in the context of aberrant OCDs. 
In support of these findings in vivo, a similar reduction in proliferation with Vangl2 depletion was previously 
reported in two basal breast cancer lines3, and we observed that Vangl2 deficiency, specifically in basal cells, 
impairs the growth of the entire cyst (Fig. 6A–C).
The fact that we observed different ductal diameter phenotypes in the MMTV-Cre;Vangl2flox/flox mammary 
gland versus Vangl2Lp/Lp outgrowths may be due to the timing of VANGL2 inactivation in these different models, 
the nature of the mutation, or both. Conditional loss of Vangl2 was achieved using a Cre driver activated during 
puberty and, while it resulted in a major reduction in VANGL2 protein18, this decrease occurred after birth. In 
contrast, the endogenous missense mutation in the Looptail version of VANGL2 influences both embryonic and 
postnatal development. In the embryonic neuroepithelium and regenerating adult muscle, VANGL2 governs the 
asymmetric cell division of stem/progenitor cells by OCD34,35. In the mammary gland, VANGL2 is expressed 
in the stem cell-containing, basal cell population. Disruption of mammary stem cell self-renewal, expansion 
and/or cell fate acquisition during embryogenesis could alter the cellular dynamics of the developing gland and 
dramatically influence ductal morphogenesis in ways that are distinct from the loss of VANGL2 during puberty. 
Moreover, recent findings describe VANGL proteins functioning together in a heteromeric protein complex that 
prevents trafficking of VANGL1 to the cell surface in Vangl2Lp/Lp mice22,36. Indeed, we observed such disruption 
of VANGL1 localization at the cell borders of Vangl2Lp/Lp tissue (Supp. Fig. 2B) This dual disruption can result in 
mislocalization of other PCP components such as Pk2, and lead to more dominant phenotypic traits22. Thus, the 
cell surface loss of both VANGL2 and VANGL1 from conception is likely to adversely affect both CE and OCD, 
and may explain the 50% decline in outgrowth potential, and the dilated ducts and other morphological pheno-
types displayed in the successful Vangl2Lp/Lp outgrowths compared to MMTV-Cre;Vangl2flox/flox mammary glands.
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A surprising result from this study was the identification of a link between the expression of BMI1 and 
VANGL2. We show that loss of VANGL2 reduces Bmi1 expression and that overexpression of Bmi1 rescues mam-
mary cyst formation. BMI1 is involved in the self-renewal and maintenance of stem cells37,38, and BMI1 KO mice 
have mammary glands that are stunted similar to Vangl2Lp/Lp outgrowths38. Furthermore, the stem cell-containing, 
basal cell population of the mammary gland expresses VANGL2 and previous studies have shown that VANGL2 
is needed for symmetric expansion of stem cell division34,35. Because the Looptail (Vangl2Lp/Lp) mutation is lethal, 
we performed anlage rescue, and this gave us our first indication of a potential stem cell defect in Vangl2Lp/Lp 
tissue. Compared to WT, there was a 50% reduced rescue of Vangl2Lp/Lp anlage, and a similar reduction in tissue 
viability with subsequent fragment passage. We also observed this decreased viability in our cyst assay when we 
reduced the level of Vangl2 expression in basal cells. We performed an in vivo serial transplantation assay that 
did not, however, reveal a difference in the passageability of WT and Vangl2Lp/Lp tissue. Although this result sug-
gests that stem cells are not adversely affected by the loss of cell surface VANGL in Vangl2Lp/Lp tissue, an alternate 
explanation is that rescued tissue contains sufficient functional VANGL2 to preserve, at least some, mammary 
stem cell viability. Dosage sensitivity of the Vangl2Lp allele is well documented39, and supported in this study by 
the phenotypic heterogeneity observed in the mammary outgrowths produced by rescued anlage. Thus, it is 
tempting to speculate that VANGL2 may promote the expansion and/or self-renewal of mammary stem cells in 
the embryo and loss of VANGL2 signaling results in the depletion of the stem cell pool. Current experiments are 
aimed at understanding if VANGL2 is regulating stem cell number in the mammary gland using the null allele. 
Furthermore, it will be interesting to determine whether such deregulation of mammary stem cell self-renewal, 
expansion and/or cell fate acquisition by VANGL2 may contribute to its cancer modulatory effects.
Methods
Mouse strains. Vangl2Lp/Lp mice were obtained from Jackson Laboratory. Vangl1CKO and Pk2+/− mice 
were generated as previously described15,28. Vangl2flox/flox mice were generated as previously described18 and were 
crossed with Tg(MMTV-cre)1Mam (line A) provided by K Wagner19. This research was both approved by and 
conducted in accordance with the guidelines set by the University of California, Santa Cruz animal care commit-
tee (IACUC) and the Peter MacCallum Cancer Centre Animal Experimental Ethics. The research was conducted 
in compliance with National Health and Medical Research Council (Australia) guidelines.
Mammary gland transplantation. Mammary anlage were dissected from Vangl2 Lp/Lp embryos, and 
transplanted into pre-cleared fat pads of Foxn1nu mice40. Contralateral outgrowths were harvested 12 weeks 
post-transplant and subjected to whole mount carmine staining. For serial studies, epithelial fragments were 
harvested and transplanted into a new host every 12 weeks.
In vivo branch quantification. Primary branches were defined as ducts extending from the site of trans-
plantation and terminating in an end bud. Secondary and tertiary branches were defined as branches extending 
from primary ducts or secondary branches, respectively. Branch number was quantified by tracing the primary 
ductal structure and counting the number of primary ducts and secondary/tertiary branches in Fiji41.
Ductal size quantification. To quantify the size of ducts in wholemounts, we measured the area of each duct in 
whole mount images using Fiji. A grid comprised of vertical lines spaced equidistant was laid on top of whole mount 
images. This provided a way to divide the ducts into equal sections. Next, single ducts were outlined and the space (area) 
occupied by that duct in each section was quantified. To quantify duct width at the histological level, all H&E stained 
duct cross-sections (24–51 ducts/mouse, 3 mice/group), were captured on a BX51-P Olympus Microscope and the 
maximum width of each duct measured using Metamorph Image Analysis software (Molecular Devices).
Immunohistochemistry and Immunofluorescence. IHC was performed as previously described with: 
Hoechst (AnaSpec, #AS-83218), anti-E-cad (Cell Signaling, #3195 S or BD biosciences, 610182), anti-VANGL2 
(SCBT, #46561), anti-VANGL1 (R&D, #HPA02235), Ki67 (Novus, NB500-170), Cleaved Caspase 3 and 
pERM (Cell Signaling #9661, #3726), Phalloidin (Invitrogen, #A12381), aSMA (DAKO, #M0851), anti-K8 
(Developmental Studies Hybridoma Bank, Troma-1), Cytokeratin 5 (Covance, #PRB-160P), and anti-K14 
(Covance, #PRB-155P). Images were collected on a Leica SP5 confocal microscope. Brightfield imaging was per-
formed on a Biorevo BZ-9000 Digital Microscope (Keyence) and confocal microscopy performed on a Nikon C2 
Confocal, Leica SP5 confocal and Solamere Spinning Disk Confocal Microscope. 3-dimensional reconstructions 
were performed using Fiji or NIS-elements.
RNA extraction and RT-qPCR. Total RNA was isolated from MEC and LEC primary cell fractions (sepa-
rated as described29) or from FACS-purified basal (Lin_CD24 + CD29-high) and luminal (Lin_CD24 + CD29low) 
cells using TRIzol reagent (Invitrogen) and prepared as previously described29. cDNA was prepared from 1 μg 
RNA using an iScript cDNA synthesis kit (Bio-Rad). RT-qPCR was performed in triplicate using LightCycler 480 
SYBR Green I Master (Roche) and quantified using either Rotor Gene 6000 real-time PCR machine and software 
or Bio-Rad CFX Connect Real-Time System and CFX Manager software (Bio-Rad). Samples were normalised to 
GAPDH and expression levels calculated using the 2−ΔCt method. Real-time primers listed in S1 Table. Results 
were normalized to that of Gapdh.
Transduction of primary mammary epithelial cells. Luminal and myoepithelial primary MECs 
were isolated by differential trypsinization as previously described29. Next, transduction of primary MECs 
was performed as described previously42. Single MECs were seeded at a density of 500,000 cells in a 24-well 
low-attachment plate and infected at an MOI of 30 with designated lentivirus in 800 µl of growth media. Cells 
were infected overnight for ∼16 h and washed three times with PBS and re-plated.
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Primary mouse mammary epithelial cell cyst assay. 3D cultures were generated using the “on top” 
Matrigel method as previously described43. Briefly, transduced luminal and myoepithelial cells were trypsinized 
into a single cells suspension. The cells were then mixed in a 1:4 myoepithelial: luminal ratio and seeded at a final 
density of 25,000 cells on Matrigel-coated 8 well chamber slides. Cells were allowed to attach to the surface of the 
Matrigel for 30 mins at 37 °C. A final volume of 10% Matrigel in growth media was added to the cells after attach-
ment. Cells were imaged and analyzed for cyst formation after 72 hrs.
Western blot analysis. Cell or whole tissue lysates were prepared and analyzed by western blot as previously 
described. Luminescence was captured onto x-ray film or by the Biorad Gel Doc XR+ imaging system. Images 
were then quantified using Image Lab with band densitometry normalized to GAPDH.
Statistical analysis. Statistical analyses (Student’s t-test and ANOVA) were conducted on Graphpad Prism. 
Significance is indicated as *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001. Bars represent SEM.
Data Availability
The datasets generated during and/or analysed during the current study are available in the Gene Expression 
Omnibus (GEO) Reference ID: GSE19446.
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